Works matching IS 11732563 AND DT 2011 AND VI 31 AND IP 5
1
- Clinical Drug Investigation, 2011, v. 31, n. 5, p. 351, doi. 10.1007/BF03256934
- Article
2
- Clinical Drug Investigation, 2011, v. 31, n. 5, p. 345, doi. 10.1007/BF03256933
- Article
3
- Clinical Drug Investigation, 2011, v. 31, n. 5, p. 337, doi. 10.1007/BF03256932
- Article
4
- Clinical Drug Investigation, 2011, v. 31, n. 5, p. 325, doi. 10.1007/BF03256931
- Article
5
- Clinical Drug Investigation, 2011, v. 31, n. 5, p. 317, doi. 10.1007/BF03256930
- Article
6
- Clinical Drug Investigation, 2011, v. 31, n. 5, p. 309, doi. 10.1007/BF03256929
- Article
7
- Clinical Drug Investigation, 2011, v. 31, n. 5, p. 299, doi. 10.1007/BF03256928
- Article
8
- Clinical Drug Investigation, 2011, v. 31, n. 5, p. 285, doi. 10.1007/BF03256927
- Article